emendrixAccount

Textual twins

Medical Devices Regulation Art. 63 and IVDR Art. 59 where the texts differ

textually similar (0.949) · paired on the Medical Devices Regulation text of 19 July 2026 and the IVDR text of 10 January 2025 · headings the same

Medical Devices Regulation Art. 63 and IVDR Art. 59 are textually similar: their words match at a ratio of 0.949, where 1 is identical text. That says nothing about what either provision requires, or whether one should change because the other did.

Where the texts differ

Each passage is a differing span with up to 6 unchanged words either side, from the text as compared, spacing collapsed, and cut at 400 characters where it ends […]. It is an excerpt for reading where the two differ, not the verbatim text.

PassageMedical Devices Regulation Art. 63IVDR Art. 59
1

Article 63 Informed consent 1. Informed consent shall

Article 59 Informed consent 1. Informed consent shall

2

her decision to participate in the clinical investigation. 2. Information given to the subject

her decision to participate in the performance study. 2. Information given to the subject

3

implications, risks and inconveniences of the clinical investigations; (ii) the subject's rights and guarantees

implications, risks and inconveniences of the performance study; (ii) the subject's rights and guarantees

4

the right to withdraw from the clinical investigation at any time without any resulting

the right to withdraw from the performance study at any time without any resulting

5

(iii) the conditions under which the clinical investigations is to be conducted, including the

(iii) the conditions under which the performance study is to be conducted, including the

6

of the subject's participation in the clinical investigation; and (iv) the possible treatment alternatives,

of the subject's participation in the performance study; and (iv) the possible treatment alternatives,

7

participation of the subject in the clinical investigation is discontinued; (b) be kept comprehensive,

participation of the subject in the performance study is discontinued; (b) be kept comprehensive,

8

is appropriately qualified under national law; (d) include information about the applicable

is appropriately qualified under national law; and (d) include information about the applicable

9

compensation system referred to in Article 69; and (e) include the Union-wide unique single

compensation system referred to in Article 65; (e) include the Union-wide unique single

10

the Union-wide unique single identification number of the clinical investigation referred to in

the Union-wide unique single identification number for the performance study referred to in

11

unique single identification number of the clinical investigation referred to in Article 70(1) and

unique single identification number for the performance study referred to in Article 66(1) and

12

clinical investigation referred to in Article 70(1) and information about the availability of

performance study referred to in Article 66(1) and information about the availability of

8 more passages not shown; read both on EUR-Lex.

Aligned sub-provisions

Medical Devices Regulation first, then IVDR, each with its word ratio.

Changes since the texts were paired

The record holds no change to either provision after the versions they were paired on.